How Aspirin Inhibits Clotting
Aspirin, or acetylsalicylic acid, reduces blood clotting by irreversibly blocking cyclooxygenase-1 (COX-1) enzyme in platelets. This stops production of thromboxane A2, a chemical that activates platelets and promotes their aggregation into clots. Effects last 7-10 days, the lifespan of a platelet, since platelets can't make new COX-1.[1]
Why Effects Differ Across People
Aspirin's impact varies due to genetics, age, dose, health conditions, and other drugs:
- Genetic Factors: CYP2C9 and other gene variants affect aspirin metabolism. Poor metabolizers (about 10-20% of Caucasians) process it slower, leading to stronger, longer anti-clotting effects. Conversely, ultra-rapid metabolizers clear it faster, reducing efficacy.[2][3]
- Age and Platelet Count: Older adults (over 65) have fewer responsive platelets and altered vessel walls, so aspirin cuts clotting risk by 20-30% less than in younger people. Children and infants metabolize it quicker, with shorter effects.[1]
- Health Conditions: Diabetics show 20-40% weaker platelet inhibition from aspirin resistance linked to high glucose and oxidative stress. Smokers and those with high BMI often need higher doses for full effect. Heart disease patients may have variable responses due to inflamed endothelium.[4]
- Dose and Timing: Low-dose (81 mg daily) mainly affects platelets without much systemic bleeding risk. Higher doses (325+ mg) inhibit clotting more broadly but increase gastrointestinal bleeding in sensitive individuals.[1]
Who Responds Poorly (Aspirin Resistance)
Up to 30% of people show "aspirin resistance," where platelets still aggregate despite treatment. Causes include non-compliance, drug interactions (e.g., ibuprofen blocks aspirin's platelet effect), or conditions like coronary stents. Lab tests like platelet function assays confirm it; resistant patients often switch to clopidogrel.[3][4]
Risks and Bleeding Differences
Aspirin raises bleeding risk unevenly—gastrointestinal bleeds occur in 1-2% yearly at low doses, higher in Asians (due to lower body weight and platelet traits) and those with ulcers or H. pylori. Brain bleeds are rare (0.1-0.3%) but more common in uncontrolled hypertensives. Women under 60 face slightly higher bleed risk than men.[1][2]
Clinical Use in Varied Populations